ChanRx

Small molecule drug candidates directed at ion channel targets to repurpose existing therapies for atrial fibrillation.

Get a Demo and See the Full Profile

Get a demo today to see profiles of ChanRx plus 5903 other startups.

Learn More About ChanRx

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More